Related Experiment Video
Updated: May 22, 2025
09:02
Manganese Oxide Nanoparticle Synthesis by Thermal Decomposition of ManganeseII Acetylacetonate
Published on: June 18, 2020
12.9K
Embracing cancer immunotherapy with manganese particles
Ali Moosavi Zenooz1,2, Majid Eterafi1, Soheil Azarmi Giglou2
1Cancer Immunology and Immunotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Cellular Oncology (Dordrecht, Netherlands)
|May 21, 2025
Summary
Manganese (Mn) and manganese nanoparticles (Mn-NP) are crucial for life and show great promise in cancer immunotherapy. They enhance immune responses, acting as vaccine adjuvants and drug carriers for advanced cancer treatments.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Immunology
- Oncology
Background:
- Manganese (Mn) is an essential trace metal vital for numerous metabolic and biological functions.
- Manganese nanoparticles (Mn-NP) are emerging as promising agents in cancer immunotherapy.
- Mn-NPs modulate key immune mechanisms, including inflammasomes and immunogenic cell death (ICD).
Purpose of the Study:
- To provide a comprehensive review of recent advancements in the application of manganese and manganese nanoparticles in cancer immunotherapy.
- To highlight the potential of Mn-NPs in enhancing immune responses against cancer.
- To offer guidance for the design and application of Mn-NPs in immune-based cancer therapies.
Main Methods:
- Literature review of recent scientific publications on manganese and manganese nanoparticles in cancer immunotherapy.
- Analysis of the mechanisms by which Mn-NPs interact with the immune system and tumor microenvironment.
- Evaluation of Mn-NPs as vaccine enhancers, drug delivery systems, and in combination therapies.
Main Results:
- Mn-NPs demonstrate significant potential in triggering immune pathways and modulating the tumor microenvironment.
- They serve as effective vaccine adjuvants, improving anti-tumor immune responses.
- Mn-NPs show promise as drug couriers and in combination with immune checkpoint inhibitors (ICIs) and phototherapies.
Conclusions:
- Manganese nanoparticles represent a significant advancement in cancer immunotherapy.
- Their multifaceted roles in modulating immune responses and tumor microenvironment offer new therapeutic strategies.
- Further research into Mn-NP design and application is warranted to optimize their use in treating cancer.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
01:30Cancer Vaccines
313
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
313
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:46Electron Transport Chain: Complex I and II
9.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.9K